CTNNB1 and hepatocellular carcinoma: In addition, analysis of published RNA-seq datasets for human primary liver tumours and cell lines showed that > 1% (6 out of 471 primary tumours, 1 out of 57 HCC cell lines) of HCC patients carried Ctnnb1 transcripts excluding exon 3 (Fig. 5e).